U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 1, Interesting) by Anonymous Coward on Wednesday January 23 2019, @05:25PM (2 children)
I'm not as educated as I would like to be in this department, but I was under the impression that most of the "good" countries had government funded healthcare, not government subsidized health care.
That distinction seems important to me, though I can't say why I'm more willing to believe that the government would make better use of its own money than someone who'd receive that money for meeting certain criteria would.
I'll have to reflect upon that opinion.
(Score: 2) by DeathMonkey on Wednesday January 23 2019, @09:25PM (1 child)
Canada has a government insurance system.
England has publicly funded services.
They're both much better than the US.
(Score: 2) by dry on Thursday January 24 2019, @06:42AM
Canada has 14 government insurance systems. We also have some of the most expensive drugs in the world, 2nd highest I believe, partially due to the fractured healthcare.